NASDAQ:BPMC - Blueprint Medicines SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$78.14 -0.44 (-0.56 %)
(As of 03/25/2019 11:57 AM ET)
Previous Close$78.58
Today's Range$76.0950 - $80.20
52-Week Range$44.58 - $103.12
Volume204,639 shs
Average Volume502,143 shs
Market Capitalization$3.45 billion
P/E Ratio-14.50
Dividend YieldN/A
Beta1.64

SEC Filings

Blueprint Medicines (NASDAQ:BPMC) SEC Filings

DateFilerForm TypeView
03/19/2019
4:25 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2019
4:23 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/18/2019
2:52 PM
Blueprint Medicines (Filer)
Form CT ORDER
View Filing
03/15/2019
3:13 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/08/2019
4:00 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
4:04 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:31 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:30 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:29 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:28 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:25 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:25 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:24 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
4:24 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
3:45 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/26/2019
3:35 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/26/2019
6:31 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
12:51 PM
Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
02/13/2019
3:04 PM
Blueprint Medicines (Subject)
Third Rock Ventures II, L.P. (Filed by)
Form SC 13G/A
View Filing
02/12/2019
8:42 AM
Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/11/2019
11:07 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/05/2019
3:15 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
7:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/03/2018
3:01 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/21/2018
6:20 AM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
7:45 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
3:25 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
3:55 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
3:52 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/30/2018
3:31 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/30/2018
6:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
3:15 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
6:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/30/2018
11:00 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/26/2018
3:30 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/25/2018
3:30 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/19/2018
3:08 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:08 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/01/2018
3:40 PM
Blueprint Medicines (Filer)
Form 10-Q/A
View Filing
08/01/2018
3:36 PM
Blueprint Medicines (Filer)
Form 10-K/A
View Filing
08/01/2018
3:31 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/01/2018
6:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/25/2018
3:57 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:57 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:56 PM
Blueprint Medicines (Issuer)
Rowland Charles A Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:56 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:55 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:55 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:54 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
3:54 PM
Blueprint Medicines (Issuer)
LYNCH DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:30 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/15/2018
7:15 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2018
6:15 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/14/2018
6:38 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:34 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2018
3:29 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/08/2018
3:57 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
3:46 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/02/2018
6:32 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/16/2018
7:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/21/2018
4:04 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/20/2018
7:02 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
4:06 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
3:55 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
5:07 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
4:12 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
4:08 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
4:06 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/21/2018
6:32 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/20/2018
4:33 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
4:33 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
4:31 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
4:31 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
4:30 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
4:29 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
5:52 PM
Blueprint Medicines (Issuer)
LYNCH DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
4:27 PM
Blueprint Medicines (Issuer)
LYNCH DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
4:23 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
7:47 AM
Blueprint Medicines (Subject)
Flynn James E (Filed by)
Form SC 13G/A
View Filing
02/13/2018
8:34 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/08/2018
10:59 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
View Filing
02/08/2018
10:32 AM
Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
01/29/2018
3:40 PM
BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
Form SC 13G/A
View Filing
01/08/2018
8:03 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/13/2017
3:52 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/13/2017
3:51 PM
Blueprint Medicines (Filer)
Form 424B5
View Filing
12/11/2017
3:15 PM
Blueprint Medicines (Filer)
Form 424B5
View Filing
12/11/2017
6:47 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Featured Article: Net Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel